OnKure Therapeutics Inc. (OKUR)

NASDAQ: OKUR · Real-Time Price · USD

2.50

0.01 (0.40%)

At close: May 01, 2025, 3:59 PM

2.62

4.80%

Pre-market: May 02, 2025, 04:36 AM EDT

OnKure Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-52.67M	-35.31M	-29.51M	-39.77M	-19.46M
Depreciation & Amortization	662K	560K	387K	50K	37K
Stock-Based Compensation	4.53M	199K	48K	n/a	n/a
Other Working Capital	-3.95M	6K	2.12M	-2.8M	514K
Other Non-Cash Items	316K	n/a	n/a	4.54M	378K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.95M	6K	2.12M	-2.8M	514K
Operating Cash Flow	-51.12M	-34.55M	-26.95M	-37.98M	-18.54M
Capital Expenditures	-52K	-246K	-1.13M	-198K	-24K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	-31.41M	n/a
Sales Maturities Of Investments	15.93M	n/a	n/a	8.23M	7.4M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	15.87M	-246K	-1.13M	-23.38M	7.38M
Debt Repayment	6M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	51.22M	-723K	-1.38M	n/a	n/a
Financial Cash Flow	116.13M	53.13M	26.46M	132.41M	47.27M
Net Cash Flow	80.89M	18.33M	-1.62M	n/a	n/a
Free Cash Flow	-51.17M	-34.79M	-28.09M	-38.18M	-18.56M